Viewing Study NCT05971602

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:52 AM
Ignite Modification Date: 2026-03-03 @ 5:33 PM
Study NCT ID: NCT05971602
Status: TERMINATED
Last Update Posted: 2025-02-25
First Post: 2023-06-14
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Efficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PBOS in Adults With Pulmonary Tuberculosis
Sponsor: Gates Medical Research Institute
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pulmonary Tuberculosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Delamanid, Bedaquiline, OPC-167832, and Sutezolid (DBOS) View
None Pretomanid, Bedaquiline, OPC-167832, and Sutezolid (PBOS) View
None Drug sensitive tuberculosis View
None Rifampicin-resistant tuberculosis (RR-TB) View
None Multi-drug resistant tuberculosis (MDR-TB) View